Takeda Pharmaceuticals USA, Inc. v. West-Ward Pharmaceutical Corp.
District Court, D. Delaware
1Opinion of the Court
MEMORANDUM OPINION
SUE L. ROBINSON, District Judge
I. INTRODUCTION
On October 3, 2014, Takeda Pharmaceuticals U.S.A., Inc. (“Takeda”) filed suit against West-Ward Pharmaceutical Corporation, Hikma Americas Inc., and Bikma Pharmaceuticals PLC (collectively, “Hik-ma”), asserting induced infringement of five patents1 under 35 U.S.C. § 271(b).2 *542(D.I. 1) Takeda is the owner of the asserted patents, all of which cover methods of administering colchicine products for the treatment of acute gout flares, as well as for concomitant administration of colchi-cine with other drugs for prophylaxis…
2Cases cited14 opinions
- Kos Pharmaceuticals, Inc. v. Andrx Corporation Andrx Laboratories, IncCourt of Appeals for the Third Circuit · 2004
- Global-Tech Appliances, Inc. v. SEB S. A.Supreme Court of the United States · 2011
- Metro-Goldwyn-Mayer Studios Inc. v. Grokster, Ltd.Supreme Court of the United States · 2005
- Manville Sales Corporation, Plaintiff/cross-Appellant v. Paramount Systems, Inc., Robert S. Butterworth and Anthony J. DisimoneCourt of Appeals for the Federal Circuit · 1990
- Dsu Medical Corporation v. Jms Co., LtdCourt of Appeals for the Federal Circuit · 2006
9 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- Otsuka Pharmaceutical Co. v. Torrent Pharmaceuticals Ltd.District Court, D. New Jersey · 2015
- Takeda Pharmaceuticals, U.S.A., Inc. v. BurwellDistrict Court, District of Columbia · 2015
- Forest Laboratories, LLC v. Sigmapharm Laboratories, LLCDistrict Court, D. Delaware · 2017
- JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITEDDistrict Court, D. New Jersey · 2023
- Takeda Pharmaceuticals U.S.A. v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2020
1 more not listed; retrieve them via the Exa API.